Biocomposites presents STIMULAN® data at the MSIS 31st Annual Open Scientific Meeting 2021
- Research findings from two studies demonstrate the antimicrobial effectiveness of STIMULAN when mixed with antibiotics
- STIMULAN is the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue
News provided by
Share this article
Share this article
KEELE, England, Aug. 4, 2021 /PRNewswire/ Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces the acceptance of two posters at the Musculoskeletal Infection Society s 31
Phoenix
Arizona
United-states
China
India
Canada
United-kingdom
Anthony-li
Prnewswire-biocomposites
Michael-harris
Phillip-laycock
Kelly-moore